• Hofseth BioCare priced a private placement of 111,154,608 new ordinary shares at NOK 1.30 each.
• Gross proceeds totaled about NOK 144.5 million.
• Settlement split into two tranches: 78,334,609 shares delivered as immediately tradable stock.
• Remaining 32,819,999 listing shares were initially issued on a non-tradable ISIN pending a listing prospectus.
• Prospectus clearance triggers transfer to the ordinary ISIN, enabling trading of the listing shares on Euronext Oslo Børs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hofseth BioCare ASA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610090812OMX_____CNEWS_EN_GNW1001277157_en) on October 09, 2026, and is solely responsible for the information contained therein.